Biophysicist Adrianus Kalmijn Dies at 88

His work revealed that sharks use an electromagnetic sense to navigate and detect prey.

Written byChloe Tenn
| 2 min read
black and white man on coast
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Adrianus Kalmijn, a pioneer in studying sharks’ “sixth sense,” died on December 7, 2021. He was 88 years old and passed away from acute myeloid leukemia in a hospital in La Jolla, California, his son Jelger Kalmijn tells The San Diego Union-Tribune.

According to an obituary by the Scripps Institution of Oceanography at UC San Diego, his wife Vera Kalmijn describes his research and life philosophy as adhering to Faraday’s principle to “remove error and discover truth.”

Kalmijn was born in Utrecht, the Netherlands on November 7, 1933. His father was a math teacher and his mother was a children’s book author, according to the Union-Tribune. After high school, he served in the military for about three years and then went on to study at Utrecht University, eventually joining the university’s faculty.

In 1971, he published what would become one of his most recognized research contributions, a study on the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • young woman smiling

    Chloe Tenn is a graduate of North Carolina State University, where she studied neurobiology, English, and forensic science. Fascinated by the intersection of science and society, she has written for organizations such as NC Sea Grant and the Smithsonian. Chloe also works as a freelancer with AZoNetwork, where she ghostwrites content for biotechnology, pharmaceutical, food, energy, and environmental companies. She recently completed her MSc Science Communication from the University of Manchester, where she researched how online communication impacts disease stigma. You can check out more of her work here.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies